Discloseable transaction - investment in a limited partnership
Filed with HKEX · · 10 pages · English
Dawnrays Pharmaceutical Holdings Ltd. on 6ix
Earlier from Dawnrays Pharmaceutical
- Dawnrays Pharmaceutical Holdings: Proposals for general mandates to issue and repurchase shares; re-election of directors and notice of annual general meeting
- Next Day Disclosure Return
- Dawnrays Pharmaceutical Holdings: Supplemental announcement in relation to 2019 annual report
- Discloseable transaction-construction agreements
- Announcement of Interim Results for the six months ended 30 June 2017
Later from Dawnrays Pharmaceutical
- 2026 Interim report
- Notification letter and reply form to registered shareholders - notice of publication of 2026 interim report
- Notification letter and request form to non-registered holder - notice of publication of 2026 interim report
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- (Revised) Next Day Disclosure Return
Follow Dawnrays Pharmaceutical into a list and get an email when it puts out news.
Follow Dawnrays Pharmaceutical